AIDS-related obsessive compulsive disorder: deconditioning based on fluoxetine-induced inhibition of anxiety.
Abel's (1993) review of treatments for obsessive compulsive disorder (OCD) indicated that both behavioral treatment (exposure with response prevention, and biological treatment (specific serotonin reuptake inhibiting drugs) are effective. It was recognized that having both available for patients is preferable because there would be situations where one treatment is more appropriate than the other. One indication for using drugs would be where situational constraints do not allow for effective exposure treatment. We present a case study of a microbiology technician with AIDS-related OCD who had an excellent response to the administration of fluoxetine without relapse when the drug was discontinued.
Kraus
R P
RP
Department of Psychiatry, University of Western Ontario, London, Canada.
Nicholson
I R
IR
D000163:Acquired Immunodeficiency Syndrome / Q000523:psychology*; D000328:Adult; D003131:Combined Modality Therapy; D003887:Desensitization, Psychologic / Q000379:methods*; D005239:Fear; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage*; D006801:Humans; D017056:Medical Laboratory Personnel / Q000523:psychology*; D008828:Microbiological Techniques; D009771:Obsessive-Compulsive Disorder / Q000523:psychology / Q000628:therapy*; D009784:Occupational Diseases / Q000523:psychology / Q000628:therapy*; D010555:Personality Inventory; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage*; D016896:Treatment Outcome
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors